Clinical Diagnosis and Treatment Recommendations for Immune Checkpoint Inhibitor-related Hematological Adverse Events
Autor: | Junling ZHUANG, Jingting ZHAO, Xiaoxiao GUO, Jiaxin ZHOU, Lian DUAN, Wei QIU, Xiaoyan SI, Li ZHANG, Yue LI, Xiaowei LIU, Hanping WANG, Daobin ZHOU |
---|---|
Jazyk: | čínština |
Rok vydání: | 2019 |
Předmět: | |
Zdroj: | Chinese Journal of Lung Cancer, Vol 22, Iss 10, Pp 676-680 (2019) |
Druh dokumentu: | article |
ISSN: | 1009-3419 1999-6187 |
DOI: | 10.3779/j.issn.1009-3419.2019.10.13 |
Popis: | Immune checkpoint inhibitors are able to reactivate the immune system therefore enhance the anti-tumor effects. However, over-activated T cells may induce immune related adverse events (irAEs). Hematological irAEs are rarely reported, which mainly represent as mono-lineage cytopenia or pancytopenia, including autoimmune hemolytic anemia (AIHA), immune thrombocytopenia (ITP), neutropenia and aplastic anemia, sometimes even lethal, such as hemophagocytic lymphohistiocytosis. The clinical manifestations of hematological irAEs will be summarized and recommendations of diagnosis and treatment are proposed. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |